ribavirin has been researched along with Lassitude in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.13) | 18.2507 |
| 2000's | 12 (25.53) | 29.6817 |
| 2010's | 31 (65.96) | 24.3611 |
| 2020's | 3 (6.38) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, YL; Hu, CC; Li, WF; Yuan, B | 1 |
| Calil-Elias, S; Crisante, VC; Cursino, CN; de Almeida, RMVR; Duarte, GDS; Giordani, F; Monteiro, PGO; Vieira, TBQ; Xavier, AR | 1 |
| Fagundes, RN; Ferreira, LEVVC; Pace, FHL | 1 |
| Bider-Canfield, Z; Cheetham, TC; Gharibian, D; Latt, NL; Louie, V; Mittal, R; Sahota, A; Yanny, BT | 1 |
| Brown, RS; Camus, G; Copans, A; Ghali, P; Guyer, B; Haubrich, R; Kang, M; Luetkemeyer, AF; Mantry, PS; Ni, L; Rossaro, L; Satapathy, SK; Shen, X; Tam, E | 1 |
| Gonzales, GR; Gonzalez, SA; Modi, AA; Nazario, HE | 1 |
| Agarwal, K; Cannon, MD; Carey, I; Childs, K; Considine, A; Dusheiko, G; Manini, MA; Mazzarelli, C; Suddle, A | 1 |
| Andersen, ES; Bukh, J; Christensen, PB; Fahnøe, U; Gerstoft, J; Kjær, MS; Laursen, AL; Mössner, B; Pedersen, MS; Røge, BT; Schønning, K; Sølund, C; Weis, N | 1 |
| Gruenhage, F; Hahn, D; Kaiser, R; Lammert, F; Meyer, MR; Stokes, CS | 1 |
| Afify, S; Alboraie, M; Algaber, MA; Doss, W; El Halwagy, H; El Kassas, M; El Latif, YA; El Tahan, A; Elsaeed, K; Elserafy, M; Omar, H | 1 |
| Capuron, L; de la Torre, R; Giménez, D; Gratacòs, M; Langohr, K; Martín-Santos, R; Moreno-España, J; Navinés, R; Solà, R; Udina, M | 1 |
| Aichelburg, MC; Breitenecker, F; Grabmeier-Pfistershammer, K; Mandorfer, M; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Scheiner, B; Trauner, M | 1 |
| Agarwal, K; Bertelsen, K; Brown, RS; Buti, M; De Masi, R; De Meyer, S; Hézode, C; Horsmans, Y; Janczewska, E; Luo, D; Nyberg, L; Paraná, R; Rizzetto, M; Sievert, W; Witek, J; Zeuzem, S | 1 |
| Brock, E; Doern, C; Pugni, L; Ronchi, A; Sánchez, PJ | 1 |
| Bayliss, MS; Crosby, RD; L'Italien, G; Mathias, S; Sapra, S | 1 |
| Brogan, AJ; Deniz, B; Miller, JD; Rubin, J; Talbird, SE; Thompson, JR | 1 |
| Beumont, M; Cerri, K; Evon, DM; Fu, M; Gilles, L; Peeters, M; Rosa, K; Scott, J; Zeuzem, S | 1 |
| Arbuckle, R; Beumont, M; Brohan, E; Fu, M; Gilles, L; Jessner, W; Panter, C; Scott, J | 1 |
| Kim, HJ; Lee, HW; Lee, YJ; Park, SJ; Yang, SY; Yoo, KY | 1 |
| Escheik, C; Estep, M; Gerber, L; Stepanova, M; Weinstein, A; Younossi, ZM | 1 |
| Felger, JC; Haroon, E; Miller, AH; Raison, CL; Woolwine, BJ | 1 |
| Cho, EJ; Cho, Y; Kim, YJ; Lee, JH; Yoon, JH; Yu, SJ | 1 |
| Arleo, A; Copetti, M; Mangia, A; Miscio, M; Piazzolla, V; Santoro, R; Squillante, MM | 1 |
| Bocquier, A; Carrieri, MP; Dabis, F; Esterle, L; Marcellin, F; Miailhes, P; Poizot-Martin, I; Protopopescu, C; Salmon-Ceron, D; Spire, B; Wittkop, L | 1 |
| Chen, H; Huang, P; Li, J; Liu, M; Wang, J; Yao, Y; Yu, R; Yue, M; Zang, F; Zhang, Y | 1 |
| Borisov, AS; Massung, B; Miller, AH; Raison, CL; Vogt, G; Woolwine, BJ | 1 |
| Poll, R | 1 |
| Zucker, DM | 1 |
| Byrnes-Blake, K; de la Torre, A; Flamm, S; Fontana, D; Freeman, J; Gordon, SC; Gray, T; Hausman, D; Hunder, NN; Lawitz, E; Lopez-Talavera, JC; Marotta, P; Muir, AJ; Shiffman, ML; Vierling, JM; Yoffe, B; Zaman, A | 1 |
| Bernsmeier, C; Duong, FH; Filipowicz, M; Heim, MH; Terracciano, L | 1 |
| Alagbe, O; Felger, JC; Hu, F; Miller, AH; Pace, TW; Raison, CL; Woolwine, BJ | 1 |
| Fischer, K; Fransen van de Putte, DE; Mauser-Bunschoten, EP; Posthouwer, D | 1 |
| Bella, R; Bertino, G; Bruno, CM; Chisari, G; Gargante, MP; Lupo, L; Malaguarnera, M; Motta, M; Neri, S; Pennisi, G; Vacante, M | 1 |
| Cole, SW; Doho, GH; Felger, JC; Hu, F; Miller, AH; Pace, TW; Raison, CL; Woolwine, BJ | 1 |
| Evon, DM; Hoofnagle, JH; Jiang, Z; Sarkar, S; Wahed, AS | 1 |
| Cacoub, P | 1 |
| Si, CW | 1 |
| Cooksley, G; Green, J; Hassanein, T; Horta E Vale, A; Lai, MY; Marinos, G; Pastore, G; Smith, C; Sulkowski, M; Trejo-Estrada, R; Wintfeld, N | 1 |
| Barry, K; Cleare, AJ; Hotopf, M; Landau, S; Maddock, C; Maulayah, P; Norris, S; Pariante, CM | 1 |
| Arase, Y | 1 |
| Asselah, T; Bourlière, M; Bouvier-Alias, M; Bronowicki, JP; Chevalier, M; Chevaliez, S; Desmorat, H; Foucher, J; Hézode, C; Lonjon-Domanec, I; Melin, P; Montestruc, F; Ouzan, D; Pawlotsky, JM; Renou, C; Tran, A; Zarski, JP | 1 |
| Kallman, J; Kincaid, J; Younossi, Z | 1 |
| Bonkovsky, H; Faris-Young, S; Huntley, B; Lyons, MF; Reddy, KR; Ryan, M; Santoro, J; Sjogren, MH; Sjogren, R; Smith, C | 1 |
| Llopis González, A; Márquez Peiró, JF; Morales Suárez-Varela, M; Pérez Peiró, C; Valero Alcocer, VE | 1 |
| Capuron, L; Majer, M; Miller, AH; Pagnoni, G; Raison, CL; Welberg, LA | 1 |
| Aitchison, KJ; Alexander, N; Binder, EB; Bull, SJ; Cassidy, E; Cleare, AJ; Cubells, JF; Hotopf, M; Huezo-Diaz, P; Maddock, C; Miller, AH; Miyazaki, C; Norris, S; Pariante, CM; Ranjith, G | 1 |
| Conjeevaram, H; Di Bisceglie, AM; Hoofnagle, JH; Kleiner, D; Lau, D | 1 |
6 review(s) available for ribavirin and Lassitude
| Article | Year |
|---|---|
[Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
Topics: Cough; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Fatigue; Fever; Humans; Influenza, Human; Meta-Analysis as Topic; Nonprescription Drugs; Nucleic Acids; Oseltamivir; Ribavirin | 2022 |
Neonatal adenoviral infection: a seventeen year experience and review of the literature.
Topics: Adenoviridae; Adenoviridae Infections; Age Factors; Antiviral Agents; Body Temperature; Cidofovir; Cohort Studies; Cough; Cytosine; Diarrhea; Fatigue; Female; Gastrointestinal Hemorrhage; Hepatomegaly; Humans; Hypotension; Hypoxia; Immunoglobulins, Intravenous; Infant, Newborn; Intensive Care Units, Neonatal; Irritable Mood; Male; Muscle Hypotonia; Organophosphonates; Pancytopenia; Polymerase Chain Reaction; Respiratory Sounds; Retrospective Studies; Ribavirin; Splenomegaly; Tachypnea; Vomiting | 2014 |
The role of the community nurse in hepatitis C diagnosis and treatment.
Topics: Antiviral Agents; Community Health Nursing; Depression; Drug Monitoring; Fatigue; Hepatitis C; Humans; Infection Control; Interferon alpha-2; Interferon-alpha; Neutropenia; Nurse's Role; Nursing Assessment; Patient Education as Topic; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Social Support; United Kingdom | 2009 |
[Treatment of extrahepatic manifestations associated with hepatitis C virus infection].
Topics: Antiviral Agents; Autoantibodies; Cryoglobulinemia; Drug Therapy, Combination; Fatigue; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Lymphoproliferative Disorders; Male; Middle Aged; Odds Ratio; Porphyria Cutanea Tarda; Pruritus; Ribavirin; Sjogren's Syndrome; Surveys and Questionnaires; Thrombocytopenia; Time Factors; Vascular Diseases | 2002 |
[Side effects of interferon therapy for chronic hepatitis C].
Topics: Antiviral Agents; Drug Therapy, Combination; Fatigue; Hepatitis C, Chronic; Humans; Interferons; Leukopenia; Mental Disorders; Ribavirin; Thrombocytopenia | 2006 |
The effects of HCV infection and management on health-related quality of life.
Topics: Antiviral Agents; Chronic Disease; Depression; Fatigue; Health Status; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin | 2007 |
21 trial(s) available for ribavirin and Lassitude
| Article | Year |
|---|---|
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Coinfection; Fatigue; Female; Fluorenes; Headache; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Pregnancy; Ribavirin; Sofosbuvir; Sustained Virologic Response; Uridine Monophosphate | 2018 |
Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study.
Topics: 2-Naphthylamine; Adult; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cyclopropanes; Drug Therapy, Combination; Fatigue; Female; Fluorenes; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sofosbuvir; Sulfonamides; Treatment Outcome; Uracil; Valine; Viral Load | 2018 |
Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Nausea; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2014 |
Measurement properties of the flu-like symptom index from the hepatitis physical symptom severity diary.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Depression; Drug Therapy, Combination; Factor Analysis, Statistical; Fatigue; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Minnesota; Musculoskeletal Pain; Psychiatric Status Rating Scales; Reproducibility of Results; Ribavirin; Self Report; Severity of Illness Index; Sickness Impact Profile; Surveys and Questionnaires; Treatment Outcome; Virginia; Young Adult | 2014 |
Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Fatigue; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; Humans; Interferon-alpha; Male; Middle Aged; Quality of Life; Ribavirin; Self Report; Simeprevir; Sulfonamides; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 an
Topics: Adolescent; Adult; Aged; Anemia; Depression; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Fatigue; Female; Hepatitis C, Chronic; Humans; Incidence; Interferons; Liver; Male; Middle Aged; Placebos; Ribavirin; Simeprevir; Treatment Outcome; Viral Load; Young Adult | 2015 |
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Recurrence; Republic of Korea; Ribavirin; RNA, Viral; Treatment Outcome | 2015 |
Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.
Topics: Adrenocorticotropic Hormone; Adult; Antiviral Agents; Circadian Rhythm; Cytokines; Depression; Enzyme-Linked Immunosorbent Assay; Fatigue; Female; Hepatitis C; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Pituitary-Adrenal System; Ribavirin; Statistics as Topic; Statistics, Nonparametric | 2010 |
An intervention to prevent symptoms associated with hepatitis C: a pilot study.
Topics: Antiviral Agents; Attitude to Health; Drug Therapy, Combination; Exercise Test; Exercise Therapy; Fatigue; Feasibility Studies; Female; Hepatitis C, Chronic; Home Care Services; Humans; Interferon-alpha; Male; Massachusetts; Middle Aged; Nursing Assessment; Nursing Evaluation Research; Pilot Projects; Quality of Life; Ribavirin; Surveys and Questionnaires; Treatment Outcome; Walking | 2010 |
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatigue; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Interleukins; Male; Middle Aged; Nausea; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2010 |
S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse.
Topics: Adult; Antiviral Agents; Arthralgia; Betaine; Diarrhea; Drug Therapy, Combination; Fatigue; Female; Gastrointestinal Agents; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; S-Adenosylmethionine; Time Factors; Treatment Outcome | 2010 |
Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue.
Topics: Antiviral Agents; Depression; Drug Therapy, Combination; Fatigue; Hepatitis C, Chronic; Humans; Hydrocortisone; Immunity, Innate; Interferon alpha-2; Interferon-alpha; Interleukin-6; Lymphocytes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polyethylene Glycols; Protein Processing, Post-Translational; Recombinant Proteins; Ribavirin; Severity of Illness Index; Time Factors | 2011 |
The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
Topics: Acetylcarnitine; Adult; Dietary Supplements; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin | 2011 |
Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.
Topics: 2',5'-Oligoadenylate Synthetase; Antiviral Agents; Computational Biology; Depression; Drug Therapy, Combination; Fatigue; Female; Gene Expression Profiling; Gene Expression Regulation; Hepatitis C, Chronic; Humans; Interferon-alpha; Leukocytes, Mononuclear; Longitudinal Studies; Male; Microarray Analysis; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; Severity of Illness Index | 2012 |
The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin | 2004 |
Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.
Topics: Adult; Antiviral Agents; Anxiety; Depression; Drug Carriers; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Substance-Related Disorders; Time Factors; Treatment Outcome | 2005 |
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Fatigue; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2006 |
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
Topics: Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Viral Load | 2007 |
[Toxicity of the treatment of chronic hepatitis C with peginterferon alpha (2a or 2b) plus ribavirin in patients not previously treated].
Topics: Alanine Transaminase; Antiviral Agents; Bilirubin; Cohort Studies; Drug Therapy, Combination; Fatigue; Fever; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Patient Dropouts; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Viral Load | 2007 |
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.
Topics: Adult; Antiviral Agents; Cohort Studies; Depression; Fatigue; Female; Gene Frequency; Genotype; Hepatitis C, Chronic; Humans; Interferon Type I; Interleukin-6; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Serotonin Plasma Membrane Transport Proteins | 2009 |
Prolonged therapy of chronic hepatitis C with ribavirin.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Bile Duct Diseases; Biopsy; Cholelithiasis; Fatigue; Female; Headache; Hematocrit; Hepacivirus; Hepatitis C; Humans; Liver; Male; Middle Aged; Ribavirin; RNA, Viral | 1996 |
20 other study(ies) available for ribavirin and Lassitude
| Article | Year |
|---|---|
Predictors of adverse drug reactions associated with ribavirin in direct-acting antiviral therapies for chronic hepatitis C.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antiviral Agents; Brazil; Carbamates; Drug Therapy, Combination; Fatigue; Female; Headache; Hepatitis C, Chronic; Humans; Imidazoles; Longitudinal Studies; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Pyrrolidines; Ribavirin; Risk Factors; Sofosbuvir; Valine | 2019 |
Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free.
Topics: Aged; Antiviral Agents; Brazil; Cohort Studies; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferons; Linear Models; Male; Middle Aged; Patient Reported Outcome Measures; Prospective Studies; Quality of Life; Ribavirin; Sustained Virologic Response | 2020 |
Real-World Experiences With a Direct-Acting Antiviral Agent for Patients With Hepatitis C Virus Infection.
Topics: Aged; Anemia; Antiviral Agents; California; Drug Therapy, Combination; Fatigue; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Patient Selection; Retrospective Studies; Ribavirin; Sex Factors; Sofosbuvir; Viral Load | 2017 |
Safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in hepatitis C genotype 1 patients including those with decompensated cirrhosis who failed prior treatment with simeprevir/sofosbuvir.
Topics: Abdominal Pain; Adult; Aged; Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Esophageal and Gastric Varices; Fatigue; Female; Fluorenes; Gastrointestinal Hemorrhage; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nausea; Prospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Uridine Monophosphate | 2018 |
Efficacy and Tolerability of Direct-Acting Antivirals for Hepatitis C in Older Adults.
Topics: Aged; Aged, 80 and over; Anemia; Antiviral Agents; Fatigue; Female; Headache; Hepatitis C, Chronic; Humans; Male; Middle Aged; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load | 2018 |
Antidepressant effects of direct-acting antivirals against hepatitis C virus-Results from a pilot study.
Topics: Actigraphy; Adult; Aged; Antiviral Agents; Depression; Exercise; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Pilot Projects; Ribavirin; Treatment Outcome; Tryptophan; Viral Load; Young Adult | 2018 |
High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4: Real world results.
Topics: Adult; Anemia; Anilides; Antiviral Agents; Cyclopropanes; Drug Therapy, Combination; Fatigue; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Male; Middle Aged; Proline; Prospective Studies; Ribavirin; Ritonavir; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Valine | 2022 |
Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antiviral Agents; Anxiety; Cohort Studies; Depression; Drug Therapy, Combination; Fatigue; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; INDEL Mutation; Interferon-alpha; Interleukin-6; Middle Aged; Point Mutation; Polyethylene Glycols; Promoter Regions, Genetic; Prospective Studies; Recombinant Proteins; Ribavirin; Serotonin; Serotonin Plasma Membrane Transport Proteins; White People | 2013 |
Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.
Topics: Anemia; Antiviral Agents; Coinfection; Drug Therapy, Combination; Fatigue; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Mental Health; Polyethylene Glycols; Prospective Studies; Quality of Life; Recombinant Proteins; Ribavirin; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2014 |
Cost-effectiveness of Telaprevir combination therapy for chronic hepatitis C.
Topics: Anemia; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Fatigue; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Models, Economic; Multicenter Studies as Topic; Oligopeptides; Outcome Assessment, Health Care; Polyethylene Glycols; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin | 2014 |
Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Biomarkers; Blood Chemical Analysis; Cytokines; Enzyme-Linked Immunosorbent Assay; Fatigue; Female; Fluorenes; Hepatitis C, Chronic; Humans; Male; Middle Aged; Retrospective Studies; Ribavirin; Sofosbuvir; Treatment Outcome | 2016 |
Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.
Topics: Adrenocorticotropic Hormone; Adult; Antiviral Agents; Area Under Curve; Corticotropin-Releasing Hormone; Depression; Dexamethasone; Fatigue; Female; Glucocorticoids; Hepatitis C; Humans; Hydrocortisone; Inflammation; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Psychiatric Status Rating Scales; Radioimmunoassay; Receptors, Tumor Necrosis Factor, Type II; Ribavirin; Tumor Necrosis Factor-alpha | 2016 |
Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Republic of Korea; Retrospective Studies; Ribavirin; RNA, Viral; Sofosbuvir; Treatment Outcome | 2015 |
The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin.
Topics: Aged; Antiviral Agents; Carbamates; Drug Administration Schedule; Drug Therapy, Combination; Fatigue; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Italy; Liver Cirrhosis; Male; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Sustained Virologic Response; Valine; Viral Load | 2016 |
Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).
Topics: Adult; Antiviral Agents; Chi-Square Distribution; Coinfection; Drug Therapy, Combination; Fatigue; Female; France; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Linear Models; Male; Middle Aged; Multivariate Analysis; Recovery of Function; Ribavirin; Risk Factors; Surveys and Questionnaires; Time Factors; Treatment Outcome; Viral Load | 2016 |
Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis.
Topics: Amides; Antiviral Agents; Asthenia; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Nausea; Quinoxalines; Randomized Controlled Trials as Topic; Ribavirin; RNA, Viral; Sulfonamides; Sustained Virologic Response; Viral Load | 2017 |
The burden of HCV treatment in patients with inherited bleeding disorders.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Blood Coagulation Disorders, Inherited; Cost of Illness; Depressive Disorder; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Quality of Life; Ribavirin; Surveys and Questionnaires; Young Adult | 2011 |
Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study.
Topics: Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatigue; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Longitudinal Studies; Male; Polyethylene Glycols; Prevalence; Recombinant Proteins; Retrospective Studies; Ribavirin; Severity of Illness Index | 2012 |
[Adverse effects of combining polyethylene glycol interferon with ribavilin on hepatitis C patients].
Topics: Antiviral Agents; Drug Therapy, Combination; Fatigue; Fever; Headache; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Pain; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2003 |
IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Basal Ganglia; Depression; Fatigue; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Psychiatric Status Rating Scales; Reaction Time; Regression Analysis; Ribavirin | 2008 |